Advances ranging from combined laser and drug therapies to innovative devices mean patients with acne no longer have to be scared of permanent scarring.
Two new studies analyzes the competencies and limitations of teaching a neural network to recognize facial acne.
An expert takes a look at both modalities in treating acne scarring, wrinkles, pigmentation issues, and actinic keratoses.
Clascoterone cream 1% phase 3 results presented at meeting.
A recent study investigated the potential adverse events around using 5-aminolaevulinic acid photodynamic therapy (ALA-PDT) for acne treatment.
A survey conducted by Dermatology Times® found that many still cannot access the iPLEDGE system. Now some have created guides to get around the issue.
The recent approval of a topical androgen receptor inhibitor fills a longtime need in acne treatment.
John Barbieri, MD, MBA, FAAD, speaking in his capacity as a member of the AADA iPLEDGE Workgroup, talks with Dermatology Times® about the recent iPLEDGE website struggles and guidance on how dermatologists should handle the situation.
Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/SGM Expert Resource Group, sits down with Dermatology Times® to discuss what changes were made to the iPLEDGE platform, examples of how the roll out has been unsuccessful, and how patients should be wary of trying to take old medications.
In this video interview, Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/SGM Expert Resource Group, explains what happened with the iPLEDGE website.